TY - JOUR T1 - Protein Kinase Cδ Mediates Platelet-Induced Breast Cancer Cell Invasion JF - Journal of Pharmacology and Experimental Therapeutics JO - J Pharmacol Exp Ther SP - 373 LP - 380 DO - 10.1124/jpet.106.103358 VL - 318 IS - 1 AU - David Alonso-Escolano AU - Carlos Medina AU - Katarzyna Cieslik AU - Anna Radomski AU - Paul Jurasz AU - Maria José Santos-Martínez AU - Tilahum Jiffar AU - Peter Ruvolo AU - Marek W. Radomski Y1 - 2006/07/01 UR - http://jpet.aspetjournals.org/content/318/1/373.abstract N2 - Platelets play an important role in carcinogenesis, but the underlying molecular mechanisms remain poorly understood. To investigate the effects of platelets on in vitro invasion of MCF7 human breast cancer cells, human MCF7 cells were used to study their interactions with platelets using aggregometry and cell invasion chambers. Zymography and quantitative polymerase chain reaction (PCR) were used to study matrix metalloproteinases (MMPs), whereas Western blot was used to study protein kinase C (PKC) δ in MCF7 cells. We observed that platelets promoted invasion of MCF7 cells (3-fold increase, p < 0.05, n = 3) and that this process correlated with a dramatic increase in MMP-9 (8 fold-increase, p < 0.001, n = 3), which is known to facilitate cancer cell invasion. Because both platelets and MCF7 cells have been shown to release MMP-9, we investigated the cellular source that accounted for this increase. The time course and the use of specific protein synthesis inhibitors demonstrated that most of the increase in MMP-9 levels derived from de novo synthesis of this protease by cancer cells. Furthermore, platelets activated PKCδ in MCF7 cells after 1 h of incubation (18.45 ± 4.75% increase, p < 0.05, n = 4-7), which, in turn, led to an up-regulation of MMP-9 mRNA (from 60 ± 20 to 1040 ± 100 pg, p < 0.001, n = 3) and protein levels (18-fold increase, p < 0.001, n = 3), with the subsequent cell invasion-promoting effects. PKCδ plays a crucial role in transducing the invasion-promoting effects of platelets in breast cancer cells, and the specific inhibition of PKCδ may be a strategy to decrease platelet-mediated cancer cell invasion. The American Society for Pharmacology and Experimental Therapeutics ER -